Net profit of Bafna Pharmaceuticals declined 72.81% to Rs 1.46 crore in the quarter ended March 2024 as against Rs 5.37 crore during the previous quarter ended March 2023. Sales declined 1.99% to Rs 41.40 crore in the quarter ended March 2024 as against Rs 42.24 crore during the previous quarter ended March 2023.For the full year,net profit declined 35.19% to Rs 7.35 crore in the year ended March 2024 as against Rs 11.34 crore during the previous year ended March 2023. Sales rose 32.18% to Rs 152.47 crore in the year ended March 2024 as against Rs 115.35 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales41.4042.24 -2 152.47115.35 32 OPM %6.9818.04 -7.2913.63 - PBDT2.737.18 -62 12.3516.95 -27 PBT1.465.65 -74 7.3511.62 -37 NP1.465.37 -73 7.3511.34 -35 Powered by Capital Market - Live News

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 May 2024Powered by Capital Market - Live News

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 February 2024.Powered by Capital Market - Live News

Net profit of Bafna Pharmaceuticals rose 54.04% to Rs 2.48 crore in the quarter ended September 2023 as against Rs 1.61 crore during the previous quarter ended September 2022. Sales rose 85.25% to Rs 40.68 crore in the quarter ended September 2023 as against Rs 21.96 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales40.6821.96 85 OPM %9.8311.57 - PBDT3.722.73 36 PBT2.481.61 54 NP2.481.61 54 Powered by Capital Market - Live News

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 9 November 2023.Powered by Capital Market - Live News